VOXYVOTE

Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials

Image by Thanks for your Like • donations welcome from Pixabay

Written by

PAM BELLUCK

in

Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.

PAM BELLUCK
Author: PAM BELLUCK

Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More posts